Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $57.3 Million - $113 Million
900,200 New
900,200 $60.2 Million
Q1 2022

May 17, 2022

SELL
$126.46 - $235.05 $205 Million - $381 Million
-1,620,800 Reduced 43.73%
2,085,500 $359 Million
Q4 2021

Feb 15, 2022

BUY
$225.82 - $368.51 $171 Million - $280 Million
759,100 Added 25.76%
3,706,300 $941 Million
Q3 2021

Nov 16, 2021

BUY
$221.9 - $484.47 $220 Million - $480 Million
990,100 Added 50.59%
2,947,200 $1.13 Billion
Q2 2021

Aug 16, 2021

SELL
$129.91 - $234.98 $571,604 - $1.03 Million
-4,400 Reduced 0.22%
1,957,100 $460 Million
Q1 2021

May 18, 2021

SELL
$109.18 - $185.98 $16.9 Million - $28.8 Million
-155,000 Reduced 7.32%
1,961,500 $257 Million
Q4 2020

Feb 17, 2021

BUY
$65.74 - $169.86 $50.4 Million - $130 Million
766,600 Added 56.79%
2,116,500 $221 Million
Q3 2020

Nov 17, 2020

BUY
$54.34 - $94.85 $21.3 Million - $37.2 Million
392,000 Added 40.92%
1,349,900 $95.5 Million
Q2 2020

Aug 17, 2020

BUY
$29.67 - $80.0 $5.09 Million - $13.7 Million
171,600 Added 21.82%
957,900 $61.5 Million
Q1 2020

May 15, 2020

BUY
$17.78 - $31.58 $13.8 Million - $24.5 Million
775,300 Added 7048.18%
786,300 $23.6 Million
Q4 2019

Feb 14, 2020

BUY
$13.93 - $21.28 $153,230 - $234,080
11,000 New
11,000 $215,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.